and Industry Statistics-Industry Associations and Professional Societies List-In-Depth Profiles of hundreds of leading companies-Industry Glossary-Buyer may register for access to search and export data at Plunkett Research OnlinePages: 546Statistical Tables Provided: 21Companies Profiled: 364Geographic Focus: GlobalA complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms.You will gain vital insights that can help you shape your own strategy for business development, product development and investments.-How is the industry evolving?-How is the industry being shaped by new technologies?-How is demand growing in emerging markets and mature economies?-What is the size of the market now and in the future?-What are the financial results of the leading companies?-What are the names and titles of top executives?Contents, Statistics, Forecasts and Analysis Include:Major Trends Affecting the Biotech & Genetics Industry1) The State of the Biotechnology Industry Today2) A Short History of Biotechnology3) Ethanol Production Soared, But a Market Glut May Slow Expansion4) Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms5) From India to Singapore to Australia, Nations Compete Fiercely in Biotech Development6) Medical Trials Conducted Abroad Spark Concerns7) Gene Therapies and Patients' Genetic Profiles Promise a Personalized Approach to Medicine8) Breakthrough Drugs for Cancer Treatment; Many More Will Follow9) Few New Blockbusters: Major Drug Patents Expire While Generic Sales Growth Continues10) Biotech and Orphan Drugs Pick Up the Slack as Blockbuster Mainstream Drugs Age11) Biogenerics (Follow-on Biologics) are in Limbo in the U.S.12) Breakthrough Drug Delivery Systems Evolve13) Stem Cells: Multiple Sources Stem from New Technologies14) U.S. Government Reverses Ban on Funding for New Stem Cell Research15) Stem Cells: Therapeutic Cloning Techniques Advance16) Stem Cells: A New Era of Regenerative Medicine Takes Shape17) Nanotechnology Converges with Biotech18) Agricultural Biotechnology Scores Breakthroughs but Causes Controversy/Selective Breeding Offers a Compromise19) Focus on Vaccines20) Ethical Issues Abound Biotech & Genetics Industry Statistics1) U.S. FDA New Drug and Biologic Approvals, 20092) U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals: 1993-20093) Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.: Fiscal Years 2008-20104) National Health Expenditure Amounts by Type of Expenditure, U.S.: Selected Calendar Years, 2004-20195) U.S. Exports & Imports of Pharmaceutical Products: 2005-1st Quarter 20106) U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: Selected Calendar Years, 2004-20197) U.S. Prescription Drug Expenditures: 1965-20198) Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-20099) Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Year 2009-201110) Sales By Geographic Area, PhRMA Member Companies: 200811) Domestic U.S. Biopharmaceutical R&D Breakdown, PhRMA Member Companies: 200812) R&D by Global Geographic Area, PhRMA Member Companies: 200813) Domestic Biopharmaceutical R&D Scientific, Professional & Technical Personnel by Function, PhRMA Member Companies: 200814) Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1970-2009

Hide more